VF
CRDF icon

Virtu Financial’s Cardiff Oncology CRDF Stock Holding History

Virtu Financial’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$93K Buy
71,328
+57,724
+424% +$91.6K ﹤0.01% 1124
2026
Q1 		$22K Sell
13,604
-24,875
-65% -$51.1K ﹤0.01% 1384
2025
Q4 		$108K Buy
+38,479
New +$89.3K ﹤0.01% 1186
2025
Q2 		– Sell
-19,212
Closed -$60K – 1558
2025
Q1 		$60K Sell
19,212
-31,969
-62% -$126K ﹤0.01% 989
2024
Q4 		$222K Buy
+51,181
New +$160K 0.01% 832
2024
Q1 		– Sell
-21,492
Closed -$32K – 1513
2023
Q4 		$32K Buy
+21,492
New +$26K ﹤0.01% 1243
2023
Q1 		– Sell
-39,358
Closed -$55K – 1603
2022
Q4 		$55K Buy
39,358
+5,047
+15% +$7.23K 0.01% 1063
2022
Q3 		$53K Buy
34,311
+21,748
+173% +$52.3K ﹤0.01% 1190
2022
Q2 		$28K Buy
+12,563
New +$21K ﹤0.01% 1266
2021
Q3 		– Sell
-19,925
Closed -$133K – 1575
2021
Q2 		$133K Sell
19,925
-13,330
-40% -$113K 0.01% 1126
2021
Q1 		$308K Buy
+33,255
New +$404K 0.02% 803
2020
Q4 		– Sell
-20,604
Closed -$292K – 1489
2020
Q3 		$292K Buy
+20,604
New +$136K 0.05% 447
2018
Q2 		– Sell
-1,471
Closed -$37K – 2038
2018
Q1 		$37K Buy
1,471
+475
+48% +$11.7K ﹤0.01% 1757
2017
Q4 		$22K Sell
996
-102
-9% -$4.52K ﹤0.01% 2206
2017
Q3 		$58K Buy
+1,098
New +$68.5K ﹤0.01% 2205

Other funds holding CRDF

LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Virtu Financial's CRDF Position: Q2 2026 in Review

Virtu Financial increased its Cardiff Oncology (CRDF) stake by 424% in Q2 2026, buying an estimated $91.6K and bringing the position to 71,328 shares worth $93K. The position accounts for ﹤0.01% of the portfolio, ranked #1124.

Virtu Financial first reported a position in CRDF in Q3 2017 and has held it in 15 quarters since. The position peaked at $308K in Q1 2021. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • Virtu Financial held 71,328 shares of Cardiff Oncology worth $93K as of Q2 2026.
  • Virtu Financial bought 57,724 Cardiff Oncology shares in Q2 2026, an estimated $91.6K.
  • Cardiff Oncology made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1124 holding.
  • Virtu Financial first reported a position in Cardiff Oncology in Q3 2017 and has held it in 15 quarters since.
  • Virtu Financial's Cardiff Oncology position peaked at $308K in Q1 2021.
  • 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.